PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-29.30%
Negative net income growth while MRVL stands at 0.46%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-2.94%
Both reduce yoy D&A, with MRVL at -5.96%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
121.68%
Some yoy growth while MRVL is negative at -74.39%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
21.28%
SBC growth while MRVL is negative at -11.99%. John Neff would see competitor possibly controlling share issuance more tightly.
-268.71%
Both reduce yoy usage, with MRVL at -173.70%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-118.57%
Both yoy AR lines negative, with MRVL at -344.91%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-73.63%
Negative yoy inventory while MRVL is 4083.91%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-239.39%
Negative yoy usage while MRVL is 403.47%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.00%
Well above MRVL's 31.89%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-58.05%
Both yoy CFO lines are negative, with MRVL at -9.08%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
35.55%
CapEx growth well above MRVL's 33.54%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
100.00%
Some acquisitions while MRVL is negative at -26.18%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-24.54%
Negative yoy purchasing while MRVL stands at 50.56%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
153.36%
Proceeds from sales/maturities above 1.5x MRVL's 38.31%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-100.00%
We reduce yoy other investing while MRVL is 26.18%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
111.50%
Investing outflow well above MRVL's 80.97%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
21.95%
We slightly raise equity while MRVL is negative at -36.68%. John Neff sees competitor possibly preserving share count or buying back shares.
-28.50%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.